Psychiatry and Neurology, Neurology · Roseville, CA
NPI
1598080053
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2 Medical Plaza Dr, Ste 205
Roseville, CA, 95661
Phone (916) 773-8711
Groups this clinician bills Medicare through
Medicare paid, 2024
$295K
34,202 services
Medicare patients, 2024
422
Average age 77
Drug cost, 2024
$2.0M
3,362 prescriptions
Company payments, 2025
$382
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erica A Byrd was code J0585 (injection, onabotulinumtoxina, 1 unit), 26,485 times for 41 patients. In total Erica A Byrd billed 34,202 services in 32 codes, and Medicare paid $295K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 26,485 | 41 | $4.87 | $129K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 560 | 336 | $13.24 | $7,413 |
| 99214 Office E&M - Established | Office | 425 | 253 | $94.72 | $40K |
| 99215 Office E&M - Established | Office | 284 | 181 | $137.74 | $39K |
| 95874 Musculoskeletal | Office | 92 | 31 | $65.45 | $6,022 |
| 64616 Musculoskeletal | Office | 78 | 25 | $152.18 | $12K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 60 | 38 | $25.94 | $1,557 |
| 99205 Office E&M - New | Office | 43 | 43 | $182.52 | $7,848 |
| 95983 Electrical Nerve Conductivity | Office | 37 | 14 | $37.89 | $1,402 |
| 64642 Musculoskeletal | Office | 35 | 12 | $87.47 | $3,061 |
| 64612 Musculoskeletal | Office | 34 | 11 | $161.40 | $5,487 |
| 99213 Office E&M - Established | Office | 21 | 20 | $72.30 | $1,518 |
| 95970 Electrical Nerve Conductivity | Office | 20 | 12 | $14.61 | $292 |
By year: 2022 $287K for 29,267 services; 2023 $266K for 29,909 services; 2024 $295K for 34,202 services.
Medicare prescription drug claims, 2024
In 2024, the drug Erica A Byrd prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 736 prescriptions and refills. In total Erica A Byrd wrote 3,362 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 736 | 1,907 | 205 | $40K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 331 | 825 | 94 | $23K |
| Donepezil Hcl Generic | 253 | 553 | 67 | $3,061 |
| Rytary Carbidopa/Levodopa | 200 | 455 | 41 | $539K |
| Primidone Generic | 167 | 459 | 53 | $6,119 |
| Gabapentin Generic | 130 | 342 | 43 | $3,525 |
| Memantine Hcl Generic | 118 | 239 | 29 | $3,784 |
| Nuplazid Pimavanserin Tartrate | 93 | 107 | 11 | $530K |
| Mirtazapine Generic | 84 | 175 | 20 | $1,878 |
| Propranolol Hcl Generic | 79 | 204 | 29 | $1,684 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 76 | 203 | 25 | $2,850 |
| Amantadine Amantadine Hcl | 72 | 171 | 24 | $5,712 |
| Rasagiline Mesylate Generic | 64 | 169 | 21 | $15K |
| Atropine Sulfate Generic | 63 | 63 | 19 | $2,536 |
| Baclofen Generic | 61 | 131 | 20 | $1,973 |
Brand drugs: 489 claims; generic drugs: 2,873 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erica A Byrd $382 ($382 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boston Scientific Corporation with $164.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.